Skip to main content

Table 5 Logistic regression to predict the effect of HP eradication on metabolic profile

From: Effect of Helicobacter pylori eradication on metabolic profile: an international, multicenter, case-control study

Variables

Non-adjusted analysis

Adjusted analysis

OR (95% CI)

P-value

OR (95% CI)

P-value

Weight

0.96 (0.9–1.3)

0.333

0.878 (0.9–1.02)

0.171

BMI

1.05 (0.82–1.35)

0.695

1.01 (0.83–1.24)

0.876

FBS

0.99 (0.96–1.01)

0.485

0.98 (0.96–1.01)

0.42

BUN

1.07 (0.93–1.23)

0.301

1.15 (0.96–1.38)

0.11

Cr

0.76 (0.16–3.43)

0.723

0.56 (0.08–3.71)

0.553

25-OH-VitD

0.98 (0.92–1.04)

0.609

1 (0.93–1.08)

0.879

TC

1 (0.99–1.01)

0.58

1 (0.99–1.01)

0.644

TG

1 (0.99–1.01)

0.783

1 (0.99–1)

0.929

HDL-C

1 (0.99–1.01)

0.287

1 (0.99–1.01)

0.526

LDL-C

0.99 (0.98–1.01)

0.763

0.99 (0.98–1.01)

0.642

VLDL-C

0.96 (0.87–1.05)

0.386

0.95 (0.85–1.06)

0.366

AST

1.02 (0.97–1.06)

0.357

1 (0.96–1.05)

0.742

ALT

0.99 (0.94–1.03)

0.678

0.98 (0.94–1.03)

0.568

ALP

1 (0.99–1)

0.332

1 (0.99–1)

0.517

  1. OR adj Adjusted odds ratio; CI Confidence interval; BMI Body mass index; Hb Hemoglobin; PLT Platelet count; MSV Mean corpuscular volume; FBS Fasting blood sugar; BUN Blood urea nitrogen; Cr Creatinine; TSH Thyroid-stimulating hormone; 25-OH-VitD 25-hydroxyvitamin D (25(OH)D); TC Total cholesterol; TG Triglyceride; HDL-C High-density lipoprotein cholesterol; LDL-C Low density lipoprotein cholesterol; VLDL-C Very low density lipoprotein cholesterol; AST Aspartate aminotransferase; ALT Alanine aminotransferase; ALP Alkaline phosphatase
  2. *adjusting for age, sex, race, comorbidities (DM, HTN, smoking); diagnosis and treatment regimen
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us